Literature DB >> 25033319

Automated combustion accelerator mass spectrometry for the analysis of biomedical samples in the low attomole range.

Esther van Duijn1, Hugo Sandman, Dimitri Grossouw, Johannes A J Mocking, Leon Coulier, Wouter H J Vaes.   

Abstract

The increasing role of accelerator mass spectrometry (AMS) in biomedical research necessitates modernization of the traditional sample handling process. AMS was originally developed and used for carbon dating, therefore focusing on a very high precision but with a comparably low sample throughput. Here, we describe the combination of automated sample combustion with an elemental analyzer (EA) online coupled to an AMS via a dedicated interface. This setup allows direct radiocarbon measurements for over 70 samples daily by AMS. No sample processing is required apart from the pipetting of the sample into a tin foil cup, which is placed in the carousel of the EA. In our system, up to 200 AMS analyses are performed automatically without the need for manual interventions. We present results on the direct total (14)C count measurements in <2 μL human plasma samples. The method shows linearity over a range of 0.65-821 mBq/mL, with a lower limit of quantification of 0.65 mBq/mL (corresponding to 0.67 amol for acetaminophen). At these extremely low levels of activity, it becomes important to quantify plasma specific carbon percentages. This carbon percentage is automatically generated upon combustion of a sample on the EA. Apparent advantages of the present approach include complete omission of sample preparation (reduced hands-on time) and fully automated sample analysis. These improvements clearly stimulate the standard incorporation of microtracer research in the drug development process. In combination with the particularly low sample volumes required and extreme sensitivity, AMS strongly improves its position as a bioanalysis method.

Entities:  

Mesh:

Year:  2014        PMID: 25033319     DOI: 10.1021/ac5015035

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  14 in total

Review 1.  Use of Accelerator Mass Spectrometry in Human Health and Molecular Toxicology.

Authors:  Heather A Enright; Michael A Malfatti; Maike Zimmermann; Ted Ognibene; Paul Henderson; Kenneth W Turteltaub
Journal:  Chem Res Toxicol       Date:  2016-10-11       Impact factor: 3.739

2.  Observational infant exploratory [(14)C]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis.

Authors:  Colin R Garner; Kevin B Park; Neil S French; Caroline Earnshaw; Alessandro Schipani; Andrew M Selby; Lindsay Byrne; Sarah Siner; Francis P Crawley; Wouter H J Vaes; Esther van Duijn; Rianne deLigt; Heili Varendi; Jane Lass; Grzegorz Grynkiewicz; Wioletta Maruszak; Mark A Turner
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

Review 3.  Opportunities in low-level radiocarbon microtracing: applications and new technology.

Authors:  Le Thuy Vuong; Qi Song; Hee Joo Lee; Ad F Roffel; Seok-Ho Shin; Young G Shin; Stephen R Dueker
Journal:  Future Sci OA       Date:  2015-12-23

4.  Successful Use of [14C]Paracetamol Microdosing to Elucidate Developmental Changes in Drug Metabolism.

Authors:  Miriam G Mooij; Esther van Duijn; Catherijne A J Knibbe; Karel Allegaert; Albert D Windhorst; Joost van Rosmalen; N Harry Hendrikse; Dick Tibboel; Wouter H J Vaes; Saskia N de Wildt
Journal:  Clin Pharmacokinet       Date:  2017-10       Impact factor: 6.447

Review 5.  Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and Science.

Authors:  Michael A Malfatti; Bruce A Buchholz; Heather A Enright; Benjamin J Stewart; Ted J Ognibene; A Daniel McCartt; Gabriela G Loots; Maike Zimmermann; Tiffany M Scharadin; George D Cimino; Brian A Jonas; Chong-Xian Pan; Graham Bench; Paul T Henderson; Kenneth W Turteltaub
Journal:  Toxics       Date:  2019-05-09

6.  Dose-linearity of the pharmacokinetics of an intravenous [14 C]midazolam microdose in children.

Authors:  Bianca D van Groen; Wouter H Vaes; B Kevin Park; Elke H J Krekels; Esther van Duijn; Lenne-Triin Kõrgvee; Wioleta Maruszak; Grzegorz Grynkiewicz; R Colin Garner; Catherijne A J Knibbe; Dick Tibboel; Saskia N de Wildt; Mark A Turner
Journal:  Br J Clin Pharmacol       Date:  2019-07-30       Impact factor: 4.335

7.  Proof of Concept: First Pediatric [14 C]microtracer Study to Create Metabolite Profiles of Midazolam.

Authors:  Bianca D van Groen; Esther van Duijn; Arjan de Vries; Miriam G Mooij; Dick Tibboel; Wouter H J Vaes; Saskia N de Wildt
Journal:  Clin Pharmacol Ther       Date:  2020-06-27       Impact factor: 6.875

Review 8.  Mini-Review: Comprehensive Drug Disposition Knowledge Generated in the Modern Human Radiolabeled ADME Study.

Authors:  Douglas K Spracklin; Danny Chen; Arthur J Bergman; Ernesto Callegari; R Scott Obach
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-07-31

9.  Pediatric microdose study of [(14)C]paracetamol to study drug metabolism using accelerated mass spectrometry: proof of concept.

Authors:  Miriam G Mooij; Esther van Duijn; Catherijne A J Knibbe; Albert D Windhorst; N Harry Hendrikse; Wouter H J Vaes; Edwin Spaans; Babs O Fabriek; Hugo Sandman; Dimitri Grossouw; Lidwien M Hanff; Paul J J M Janssen; Birgit C P Koch; Dick Tibboel; Saskia N de Wildt
Journal:  Clin Pharmacokinet       Date:  2014-11       Impact factor: 6.447

10.  Nanotracing and cavity-ring down spectroscopy: A new ultrasensitive approach in large molecule drug disposition studies.

Authors:  Nicole A Kratochwil; Stephen R Dueker; Dieter Muri; Claudia Senn; HyeJin Yoon; Byung-Yong Yu; Gwan-Ho Lee; Feng Dong; Michael B Otteneder
Journal:  PLoS One       Date:  2018-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.